Nonclinical evaluation of abuse liability of the dual orexin receptor antagonist lemborexant
Author:
Publisher
Elsevier BV
Subject
Toxicology,General Medicine
Reference49 articles.
1. Orexin-1 and orexin-2 receptor antagonists reduce ethanol self-administration in high-drinking rodent models;Anderson;Front. Neurosci.,2014
2. Zaleplon and triazolam: drug discrimination, plasma levels, and self-administration in baboons;Ator;Drug Alcohol Depend.,2000
3. Self-administration of barbiturates and benzodiazepines: a review;Ator;Pharmacol. Biochem. Behav.,1987
4. In vitro and in silico characterization of lemborexant (E2006), a novel dual orexin receptor antagonist;Beuckmann;J. Pharmacol. Exp. Therapeut.,2017
5. Preclinical in vivo characterization of lemborexant (E2006), a novel dual orexin receptor antagonist for sleep/wake regulation;Beuckmann;Sleep,2019
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Orexin-mediated motivated arousal and reward seeking;Peptides;2024-10
2. Abuse potential assessment of the dual orexin receptor antagonist daridorexant in rats;Journal of Psychopharmacology;2023-12
3. The orexin story and orexin receptor antagonists for the treatment of insomnia;Journal of Sleep Research;2023-04-22
4. The abuse potential of lemborexant, a dual orexin receptor antagonist, according to the 8 factors of the Controlled Substances Act;Psychopharmacology;2023-02-07
5. Emerging pharmacological treatments for cannabis use disorder;International Journal of Drug Policy;2022-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3